Surgery Partners, Inc.SGRYNASDAQ
Loading
Net Income Growth Recovery in ProgressRecovering
Percentile Rank72
3Y CAGR+74.4%
5Y CAGR-20.8%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+74.4%/yr
vs -30.3%/yr prior
5Y CAGR
-20.8%/yr
Recent acceleration
Acceleration
+104.7pp
Accelerating
Percentile
P72
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 33.92% |
| Q3 2025 | -808.00% |
| Q2 2025 | 93.37% |
| Q1 2025 | 65.25% |
| Q4 2024 | -242.27% |
| Q3 2024 | -104.52% |
| Q2 2024 | -25.00% |
| Q1 2024 | -1140.00% |
| Q4 2023 | 79.59% |
| Q3 2023 | -125.93% |
| Q2 2023 | 175.90% |
| Q1 2023 | -6.41% |
| Q4 2022 | 6.40% |
| Q3 2022 | -35.87% |
| Q2 2022 | -250.82% |
| Q1 2022 | 12300.00% |
| Q4 2021 | 99.56% |
| Q3 2021 | 14.87% |
| Q2 2021 | -28.10% |
| Q1 2021 | -481.82% |
| Q4 2020 | 108.93% |
| Q3 2020 | -89.54% |
| Q2 2020 | -18.18% |
| Q1 2020 | -51.10% |
| Q4 2019 | -15.92% |
| Q3 2019 | 20.71% |
| Q2 2019 | 1.49% |
| Q1 2019 | 86.40% |
| Q4 2018 | -604.17% |
| Q3 2018 | -7.80% |
| Q2 2018 | -11.08% |
| Q1 2018 | 45.55% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | -62.35% |
| Q1 2017 | -116.33% |
| Q4 2016 | 821.21% |
| Q3 2016 | -210.28% |
| Q2 2016 | 129.49% |
| Q1 2016 | -142.95% |